Results 121 to 130 of about 706,173 (166)

Calcinosis Cutis Universalis: A Review of Therapeutic Strategies and Surgical Management. [PDF]

J Clin Med
Giacometti E, Martineau J, Petrou IG, Kalbermatten DF, Scampa M.   +4 more
europepmc   +1 more source

Ixekizumab for genetically confirmed type 5 pityriasis rubra pilaris with a CARD14 p.Met119Thr variant. [PDF]

An Bras Dermatol
Tolun OF, Demir Y, Engin B.
europepmc   +1 more source

The Therapeutic Effects of Semaglutide in Congenital Linear Scleroderma. [PDF]

Cureus
Chen H, Elhawi M, Tarbox M.
europepmc   +1 more source

Incidence and prevalence of juvenile SSc in the United States: An analysis by age group. [PDF]

J Scleroderma Relat Disord
Mattson J, Bao H, Flack M, Coeytaux K.
europepmc   +1 more source

Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome. [PDF]

Int J Womens Health
Suwarsa O, Hidayah RMN, Avriyanti E, Sutedja E, Pangastuti M, Firdaus CP, Achdiat PA, Pratama DG.   +7 more
europepmc   +1 more source

Long-term follow-up of linear scleroderma en coup de sabre in children with central nervous system involvement. [PDF]

Front Immunol
Chang X, Ren L, Wu Y, Zhang Y, Wei C, Zhang Q, Zhang M, Zhao C, Bao X.   +8 more
europepmc   +1 more source

The coincidental association between isotretinoin therapy and onset of pachydermodactyly: A case report. [PDF]

JAAD Case Rep
Larrinaga JM, Bajaj S, Caravaglio JV.
europepmc   +1 more source

Maternal weight and hypertension as risk factors for juvenile idiopathic arthritis: a prospective population-based pregnancy cohort study. [PDF]

RMD Open
Dåstøl VØ, Caspersen IH, Haftorn KL, Hestetun SV, Bastakoti S, Andreassen O, Brantsæter AL, Håberg SE, Costenbader KH, Størdal K, Sanner H.   +10 more
europepmc   +1 more source

Proceedings of the 33rd European Paediatric Rheumatology Congress. [PDF]

Pediatr Rheumatol Online J
europepmc   +1 more source

Treatment in Juvenile Scleroderma

Current Rheumatology Reports, 2020
Purpose of Review: Treatment of scleroderma in children is challenging since little is known about its pathogenesis. Herein, we review the most recent evidence regarding the treatment of juvenile scleroderma.
Zulian Francesco, Francesca Tirelli
exaly   +2 more sources